Boston Scientific Corp has agreed to buy the global surgical business of privately-held Lumenis Ltd for $1.07 billion in cash, as the medical device maker looks to add an array of laser systems used in treating kidney...
Carlyle to exit clinic chain Ameos as founder, ICG take full control: sources
Buyout group Carlyle is selling Swiss-headquartered clinic chain Ameos in a deal that will see the company’s founder and private equity firm Intermediate Capital Group (ICG) take full control, people close to the matter...
Siemens Healthineers gains EU nod for $16.4 billion Varian buy
EU antitrust regulators on Friday cleared with conditions Siemens Healthineers’ $16.4 billion acquisition of U.S. peer Varian, paving the way for the German health group to become a world leader in cancer care therapy...
Supreme Court asks 17 lenders to explain Fortis Healthcare’s stake sale
The Supreme Court on Thursday directed 17 lenders, banks and financial institutions to explain the share sale by Fortis Healthcare’s former promoters Malvinder Singh and Shivinder Singh. Passing a slew of...
EU antitrust regulators to okay Siemens Healthineers’ $16.4 billion Varian buy – sources
EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers’ $16.4-billion bid for U.S. peer Varian Medical Systems Inc, three people familiar with the matter said. The EU...
Healthcare group Sanofi launches buyout offer for rival Kiadis
French healthcare group Sanofi has launched a takeover offer for smaller peer Kiadis, the companies said on Friday, in a deal that would value Kiadis’ at around 220 million euros ($265 million). Sanofi’s takeover offer...
CCI approves acquisition of Varian Medical Systems by Siemens Healthineers
The Competition Commission of India (CCI) on Wednesday said it has given nod to acquisition of 100 per cent shares and sole control of Varian Medical Systems by Siemens Healthineers. As per a combination notice filed...
Qiagen is interested in organic growth and acquisitions – CEO
Genetic testing specialist Qiagen’s Chief Executive Thierry Bernard said the company is interested in organic growth and “bolt-on” acquisitions when asked about recent merger and acquisition speculation during a results...
Bayer reaches $2 billion deal over future Roundup cancer claims
Bayer AG struck a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, the German company said on Wednesday. Bayer has been struggling to finalize the settlement of...
Indegene to raise $200 mn from Carlyle, Brighton Park
Healthcare solutions firm Indegene Pvt. Ltd said it is raising $200 million from US-based investment firms Carlyle Group and Brighton Park Capital to boost acquisitions and drive global expansion plans. Carlyle and...
MediBuddy raises $40 million in Series B funding
Digital healthcare platform MediBuddy on Tuesday said that it has closed its Series B funding at $40 million led by India Life Sciences Fund III, LLC, along with participation from other investors. The company had...
Horizon Therapeutics boosts rare-disease portfolio with $3.05 billion Viela buy
Horizon Therapeutics Plc on Monday agreed to buy Viela Bio Inc for about $3.05 billion in a move to expand its rare-disease portfolio. Viela’s only approved drug, Uplizna, is used to treat a rare, severe...
